PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-264

  1. 2,143 Posts.
    lightbulb Created with Sketch. 576
    I read the initial (2014) prospectus that had him listed as the CSO, but the prospectus that was filed in Aug ‘15 didn’t mention him in the management team. I know that PAR had trouble raising money for the float so things may have changed...but I don’t know the reason for exactly why.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.